buy medicine online indiamedicine onlineloading...


    Information about Teneligliptin

    Teneligliptin uses

    Teneligliptin is used in the treatment of type 2 diabetes mellitus. It is used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes.

    How teneligliptin works

    Teneligliptin is an anti-diabetic medication. It works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This reduces the fasting and postmeal sugar levels.

    Common side effects of teneligliptin

    Headache, Hypoglycaemia (low blood sugar level) in combination with insulin or sulphonylurea, Upper respiratory tract infection, Nasopharyngitis (inflammation of the throat and nasal passages)
    Content Details
    Written By
    Dr. Betina Chandolia
    MDS, BDS
    Reviewed By
    Dr. Shilpa Garcha
    MD (Pharmacology), MBBS
    Last updated on:
    10 Sep 2019 | 05:19 PM (IST)
    Want to know more?
    Read Our Editorial Policy

    Available Medicine for Teneligliptin

    • ₹139
      Zydus Cadila
      1 variant(s)
    • ₹65
      Mankind Pharma Ltd
      1 variant(s)
    • ₹178
      Glenmark Pharmaceuticals Ltd
      1 variant(s)
    • ₹132
      Eris Lifesciences Ltd
      1 variant(s)
    • ₹178
      Glenmark Pharmaceuticals Ltd
      1 variant(s)
    • ₹96
      Micro Labs Ltd
      1 variant(s)
    • ₹63
      Macleods Pharmaceuticals Pvt Ltd
      1 variant(s)
    • ₹108 to ₹236
      Intas Pharmaceuticals Ltd
      4 variant(s)
    • ₹119
      Torrent Pharmaceuticals Ltd
      1 variant(s)
    • ₹154
      Alembic Pharmaceuticals Ltd
      1 variant(s)

    Expert advice for Teneligliptin

    • Take it at the same time every day to help you remember to take it.
    • Be careful while driving or operating machinery until you know how Teneligliptin affects you.
    • It may cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
    • Always carry some sugary food or fruit juice with you in case you experience hypoglycemia symptoms such as cold sweats, cool pale skin, tremor, and anxiety.
    • Inform your doctor if you notice joint pains or develop symptoms such as stomach pain, nausea, and/or vomiting.

    Frequently asked questions for Teneligliptin


    Q. Can Teneligliptin cause hypoglycemia?

    Yes, Teneligliptin can cause hypoglycemia. The episodes of hypoglycemia are more common when other antidiabetic drugs and insulin are given in combination with Teneligliptin.

    Q. Is Teneligliptin the same as metformin?

    No, Teneligliptin is not the same as metformin. Although both are antidiabetic medications, their way of acting is different. Teneligliptin acts by improving the utilization of glucose by the body and increasing satiety (feeling full) and by delaying the emptying of the stomach. This makes the person feel full for longer and decreases the urge to eat. On the other hand, Metformin acts by varied mechanisms like it decreases the glucose production from the liver, decreases absorption of glucose from the intestine after taking food, and improves the sensitivity of the body organ and muscles to insulin. This helps improve the uptake of glucose from the blood.

    Q. Is Teneligliptin safe in diabetic patients with kidney failure?

    Yes, there is evidence that suggests that Teneligliptin is safe to use in patients who have developed renal failure due to diabetes. It improves blood sugar control in diabetics and also improves kidney function in impaired kidney disease associated with diabetes.

    Q. What is the role of Teneligliptin?

    Teneligliptin is a medicine that is prescribed in adults with type 2 diabetes mellitus along with diet control and exercise. It is given alone when the patient has kidney problems and cannot be prescribed metformin. It may also be given as combination therapy along with insulin or other antidiabetic drugs to adequately control the blood glucose level.

    Content on this page was last updated on 10 September, 2019, by Dr. Varun Gupta (MD Pharmacology)